+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Zarontin"

From
Antiepileptic Drugs Market - Forecast (2022 - 2027) - Product Thumbnail Image

Antiepileptic Drugs Market - Forecast (2022 - 2027)

  • Report
  • January 2022
  • 137 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Zarontin (ethosuximide) is a medication used to treat certain types of seizures in people with epilepsy. It is a central nervous system (CNS) drug, and is classified as an anticonvulsant. Zarontin works by decreasing the abnormal electrical activity in the brain that causes seizures. It is usually taken twice a day, with or without food. The Zarontin market is a subset of the larger CNS drug market. It is composed of generic and branded versions of the drug, as well as other anticonvulsants. The market is highly competitive, with many companies vying for market share. Some of the companies in the Zarontin market include Pfizer, GlaxoSmithKline, Novartis, Mylan, and Teva Pharmaceuticals. Show Less Read more